Drugs / Hidroferol®
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT01442272 Comparator | Jan → Oct 2012 | chronic renal failure syndrome, vitamin D deficiency | Hospital Universitario de Canarias | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Hidroferol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01442272 ↗ |
| Route | Oral | “Hidroferol® drinkable ampoule in oral solution, 266 mcg (1 drinkable ampoule) each 15 days during 12 months” NCT01442272 ↗ |